Rozerem - MSN Newsfeeds
- Street.Com - The FDA's action, announced Wednesday, covers 13 drugs, most notably Ambien and Ambien CR from Sanofi-Aventis ( SNY - Cramer's Take - Stockpickr ), Lunesta from Sepracor ( SEPR - Cramer's Take - Stockpickr ), Rozerem from Takeda and Sonata from King ...
- KFOX 14 - Sleep-driving is defined as driving while not fully awake after taking one of the products, with no memory of the event. Thirteen medications -- Ambien, Butisol sodium, Carbrital, Dalmane, Doral, Halcion, Lunesta, Placidyl, Prosom, Restoril, Rozerem ...
- Channel 3000 - Sleep-driving is defined as driving while not fully awake after taking one of the products, with no memory of the event. Thirteen medications -- Ambien, Butisol sodium, Carbrital, Dalmane, Doral, Halcion, Lunesta, Placidyl, Prosom, Restoril, Rozerem ...
- United Press International - ... ordered the pharmaceutical companies to notify healthcare providers about the new warnings. The medications of concern to the FDA are: Ambien/Ambien CR, Butisol Sodium, Carbrital, Dalmane, Doral, Halcion, Lunesta, Placidyl, Prosom, Restoril, Rozerem ...
- Herald Tribune - In addition to Ambien and Lunesta, the drugs targeted by the agency include Sonata and Rozerem, and a number of older medications. The FDA's move follows a warning last month by authorities in Australia, where Ambien is marketed as Stilnox. The ...
- All Headline News - Halcion; Lunesta; Placidyl; Prosom; Restoril; Rozerem; Seconal and Sonata. Copyright © AHN Media Corp - All rights reserved. Redistribution, republication. syndication, rewriting or broadcast is expressly prohibited without the prior written consent ...
- 13 WHAM - The FDA's action, announced Wednesday, covers 13 drugs, most notably Ambien and Ambien CR from Sanofi-Aventis, Lunesta from Sepracor, Rozerem from Takeda and Sonata from King Pharmaceuticals. "There are a number of prescription sleep aids available ...
- Chicago Tribune - TAP said it will sell Takeda's sleeping pill, Rozerem, as well as the drug Amitiza for chronic constipation. The co-promotion deals negotiated between TAP and Takeda come in the wake of statements made last month by Abbott Chief Executive Miles White ...
- NorthJersey.com - Medco's analysis of prescriptions included Ambien, Lunesta and Sonata, which are controlled substances under federal law, and Rozerem, a non-controlled prescription medication for insomnia. Doctors said they are worried about the marked rise in ...
- Brandweek - NEW YORK -- The apparent failure of the Rozerem ad campaign to sell the product ( Brandweek , Jan. 8 ) didn't surprise researcher Lee Weinblatt . "We could have told them that a long time ago. The beaver was a turnoff." Weinblatt isn't going with his ...
- PR Newswire - Donnelley Yellow Pages, Spice Islands, Ski- Doo, Takeda Pharmaceuticals' Rozerem, WellCare Health Plans and [yellow tail] wine. Cramer-Krasselt's public relations subsidiary, CKPR, is ranked among the nation's top 15 agencies. For more information ...
- Brandweek - Sometimes marketers can do almost everything right to launch a product, but it still doesn't catch on. That apparently is the case with Rozerem, an insomnia drug from Takeda. In the sleep drug category, which is known for advertising clichés like ...
- Brandweek - NEW YORK -- Sometimes marketers can do almost everything right to launch a product, but it still doesn't catch on. That apparently is the case with Rozerem, an insomnia drug from Takeda. In the sleep-drug category, which is known for advertising ...
- 24-7PressRelease.com - Sleep aids such as rozerem are safer now as it is found to have less risks of abuse as compared to other sleep medications. /24-7PressRelease/ - NEW YORK, NY, October 29, 2006 - Great news for people who suffer from insomnia or sleep disorders is ...
- Enid News & Eagle - Rozerem works in an entirely different way, affecting melatonin receptors that regulate the sleep-wake cycle. Although these medications are less likely than older sleeping pills or over-the-counter remedies to cause habituation, tolerance or side ...
- Austin American-Statesman - The survey was conducted by Braun Research and sponsored by Takeda Pharmaceuticals, which makes the prescription sleep aid Rozerem. The poll found that 54 percent of mothers said they don't get enough sleep. Not surprisingly, harried working moms ...
- WOOD - Researchers from The Johns Hopkins School of Medicine in Baltimore looked at ramelteon (Rozerem), a drug recently approved to treat insomnia. The medication works through a different pathway in the brain that involves melatonin receptors. Researchers ...
- 24-7PressRelease.com - Insomnia or sleeping disorders can be treated effectively with medications such as rozerem that has controlled substances or drugs that have certain government restrictions imposed on it partly because of its potential or being addictive. Some of the ...
- KRON4 - Researchers from The Johns Hopkins School of Medicine in Baltimore looked at ramelteon (Rozerem), a drug recently approved to treat insomnia. The medication works through a different pathway in the brain that involves melatonin receptors. Researchers ...
- Dayton Daily News - The survey was conducted by Braun Research and sponsored by Takeda Pharmaceuticals, which makes the prescription sleep aid Rozerem. The poll found that 54 percent of mothers said they don't get enough sleep. Not surprisingly, harried working moms ...
Pages: Previous 1 2 3 4 5 6 Next






